Grinta

Grinta is an exceptional team of serial healthcare entrepreneurs on a mission to improve access to and affordability of medicines in Egypt and Africa. By empowering pharmacies to be more efficient at running their business, fixing a broken supply chain end-to-end, and partnering with all stakeholders in the value chain they will realise this vision. We're proud to be doubling down on Grinta for this funding round as they expand across Africa.

We're excited to partner with Grinta to help enable their vision of delivering customer-centric, data-driven, and fintech-enabled solutions to modernise the pharmaceutical supply chain in Egypt and beyond. We look forward to supporting the Grinta team on their journey to build a digital and cashless bridge between underserved individual pharmacy owners and all stakeholders across the pharma value chain.

Grinta represents our 10th investment in Egypt, making Endeavor Catalyst proudly one of the most active international investors in the country. But more than attracting attention and capital to the region, Mohamed Azab's latest achievement advances the entire healthcare industry. As an Endeavor Entrepreneur and Board Member, we have witnessed how Azab's multiplier effect has impacted the local ecosystem. Our recent mapping showed that he alone has already inspired, invested, and mentored more than 100 local businesses in the Middle East, and this is only the beginning. We are huge fans of Azab and his team, knowing they can lead the next frontier of innovation in Egypt.

We are thrilled to partner with Grinta as they redefine the healthcare and pharmaceutical landscape. Their strategic pivot into primary care and retail showcases their ability to anticipate and adapt to market needs, positioning them as leaders in the region.